SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tharos who wrote (8108)12/23/1998 12:55:00 AM
From: aknahow  Read Replies (1) of 17367
 
Sometimes Pavlov rings the bell late.

Not a novel patent, but better than no patent. <g>

1 of 39)

United States Patent
5,851,802
Better
Dec. 22, 1998

Methods for recombinant microbial production of fusion proteins and BPI-derived peptides

Abstract

The present invention relates to methods and materials for the recombinant microbial production of fusion proteins and
peptides derived from or based on Domain I (amino acids 17-45), Domain II (amino acids 65-99) and Domain III (amino
acids 142-169) of bactericidal/permeability-increasing protein (BPI).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext